Understanding Influenza Vaccine Effectiveness in Senegal

This fact sheet describes a phase 4, post-licensure influenza vaccine effectiveness study that PATH and its partners are conducting in Senegal. The study seeks to better understand the extent of the influenza disease burden in tropical Africa, as well as the potential of current seasonal influenza vaccines to reduce influenza-related deaths in the developing world. Ultimately, study data could help public health officials decide how to best use influenza vaccines in Senegal and in similar tropical countries.

Publication date: May 2011

Available materials

  1. English

    1. Understanding Influenza Vaccine Effectiveness in Senegal 163.6 KB PDF
      Hard copies are not available.
  2. French

    1. Understanding Influenza Vaccine Effectiveness in Senegal [French] 652.4 KB PDF